20. November 2009 00:04
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.
[More]
19. November 2009 05:55
The December 2009 issue of the Journal of General Physiology (JGP) contains a paper by Christopher Ahern (The University of British Columbia, Vancouver) and colleagues that explores pore mutation effects in Shaker and other K+ channels using in vivo nonsense suppression technology. The study will be published online November 16 (www.jgp.org).
[More]
18. November 2009 08:24
CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA.
[More]
17. November 2009 04:13
Research and Markets (http://www.researchandmarkets.com/research/63cb3f/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Neurological Disease" to their offering.
[More]
3cce24a5-df8d-4ff4-91db-360afa454a74|0|.0
Posted in: Medical Condition News
Tags: Alzheimer's Disease, Autophagy, Calcium, Cell, Epilepsy, Fibroblast, Gene Therapy, Huntington's Disease, Immunotherapy, Insomnia, Macrophage, Migraine, Multiple Sclerosis, Myelin, Neurological Disease, Neurology, Parkinson's Disease, Pfizer, Potassium, Potassium Channel, Restless Legs Syndrome, Stem Cell, Stroke
16. November 2009 07:01
Targeted postmortem testing to identify genetic mutations associated with sudden unexplained death (SUD) is an effective and less expensive way to determine risk to relatives than comprehensive cardiac testing of first degree relatives, according to research presented at the American Heart Association's Scientific Sessions 2009.
[More]
16. November 2009 05:55
Research and Markets (http://www.researchandmarkets.com/research/4fdc99/the_renal_system_a) has announced the addition of John Wiley and Sons Ltd's new report "The Renal System at a Glance, 3rd Edition" to their offering.
[More]
10. November 2009 04:38
In attempts to improve the nutritional quality of school meals, there have been several strides forward - including the removal of soft drinks and other less nutritious menu options. However, some schools and activist groups are calling for a new change that many health professionals agree could cause more harm than good when it comes to children's health: removing chocolate milk from the lunch line.
[More]
a87e659f-a94a-4f30-8c08-627948b9a65a|0|.0
Posted in: Miscellaneous News
Tags: Bone, Calcium, Diet, Education, Exercise, Health and Human Services, Nutrition, Obesity, Pediatrics, Potassium, Vitamin D, Zinc
6. November 2009 00:33
Prevalence of lactose intolerance may be far lower than previously estimated, according to a study in the latest issue of Nutrition Today. The study, which uses data from a national sample of three ethnic groups, reveals that the overall prevalence rate of self-reported lactose intolerance is 12 percent - with 7.72 percent of European Americans, 10.05 percent of Hispanic Americans and 19.5 percent of African Americans who consider themselves lactose intolerant.
[More]
5. November 2009 07:54
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.
[More]
8ff77ca2-571a-46e3-884c-ad4815778782|0|.0
Posted in: Business / Finance
Tags: Allergy, Antisense, Arthritis, Asthma, Avastin, Bevacizumab, Bone, Cancer, Cell, Collagen, Colorectal Cancer, Cytokines, Diarrhea, DNA, Erlotinib, Etanercept, Gene Expression, Headache, Hepatitis C, Kidney Cancer, Lung Cancer, Nausea, Non-Small Cell Lung Cancer, Oligonucleotides, Oncology, Pathology, Pfizer, Potassium, Renal Cell Carcinoma, Respiratory Disease, Rheumatology, Ribavirin, Small Cell Lung Cancer, Tarceva, Vaccine, Virus
4. November 2009 08:16
Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.
[More]
4. November 2009 02:08
Researchers at the University of Maryland School of Medicine have made an important discovery about why potassium builds up to dangerous levels in the bloodstream, a relatively common medical problem that affects about eight percent of hospitalized patients.
[More]
3. November 2009 23:57
In a recent scientific study just published in the Journal of Applied Physiology, Bangsbo and co-workers demonstrate that by reducing the volume of training by 25% and introducing the so-called speed endurance training (6-12 30-s sprint runs 3-4 times a week), endurance trained runners can improve not only short-term but also long-term performance.
[More]
27. October 2009 06:47
Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development
[More]
b93d183d-3e54-472a-b77b-d8bfbf242761|0|.0
Posted in: Pharmaceutical News
Tags: Alzheimer's Disease, Anxiety, Biotechnology, Calcium, Cardiovascular Disease, Cystic Fibrosis, Depression, Dronedarone, Epilepsy, Fibrosis, Glaucoma, Oncology, Parkinson's Disease, Potassium, Potassium Channel, Schizophrenia, Tinnitus
24. October 2009 07:16
DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will deliver 43 abstracts—40 posters and three oral presentations—at this year’s American Society of Nephrology’s (ASN) Renal Week to be held in San Diego, Calif., from Oct. 27 – Nov. 1, 2009.
[More]
89e701e6-270d-4db7-9e96-3ad7f8302fbe|0|.0
Posted in: Medical Condition News | Healthcare News
Tags: Bone, Bone Mineral Density, Catheter, Creatinine, Dialysis, Education, Erythropoietin, Hyperparathyroidism, Influenza, Kidney Disease, Medicaid, Medicare, Metabolism, Nephrology, Nutrition, Obesity, Polycystic Kidney Disease, Potassium, Vitamin D, Vitamin D Deficiency
22. October 2009 08:06
Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-closing merger-related expenses. Third-quarter GAAP EPS was $1.61.
[More]
cbc59315-7610-4c1c-8b01-4e77137fb8ca|0|.0
Posted in: Business / Finance
Tags: Antiretroviral, Asthma, Cancer, Cervical Cancer, Diabetes, Gardasil, Gastroenteritis, Herpes, Herpes Zoster, Investment, Losartan, Measles, Metformin, Mumps, Nexium, Potassium, Rhinitis, Rotavirus, Shingles, Type 2 Diabetes, Vaccine, Virus, Vytorin, Zocor, Zolinza
Subscribe